KR101776362B1 - 무피로신 또는 그것의 염의 약학적 또는 수의학적 무수 국소 겔 조성물 - Google Patents

무피로신 또는 그것의 염의 약학적 또는 수의학적 무수 국소 겔 조성물 Download PDF

Info

Publication number
KR101776362B1
KR101776362B1 KR1020137011960A KR20137011960A KR101776362B1 KR 101776362 B1 KR101776362 B1 KR 101776362B1 KR 1020137011960 A KR1020137011960 A KR 1020137011960A KR 20137011960 A KR20137011960 A KR 20137011960A KR 101776362 B1 KR101776362 B1 KR 101776362B1
Authority
KR
South Korea
Prior art keywords
present
composition
rti
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137011960A
Other languages
English (en)
Korean (ko)
Other versions
KR20130124504A (ko
Inventor
카를로스 곤잘레즈 오헤르
베아트리즈 고니 알로
피오나 파스토 페르난데즈
카예타나 야르노즈 드 미구엘
Original Assignee
라보라토리오스 오제르 파르마, 에스.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라토리오스 오제르 파르마, 에스.엘. filed Critical 라보라토리오스 오제르 파르마, 에스.엘.
Publication of KR20130124504A publication Critical patent/KR20130124504A/ko
Application granted granted Critical
Publication of KR101776362B1 publication Critical patent/KR101776362B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020137011960A 2010-10-20 2011-10-19 무피로신 또는 그것의 염의 약학적 또는 수의학적 무수 국소 겔 조성물 Active KR101776362B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382274.8 2010-10-20
EP10382274A EP2444067A1 (en) 2010-10-20 2010-10-20 Anhydrous gel comprising mupirocin
PCT/EP2011/068242 WO2012052472A1 (en) 2010-10-20 2011-10-19 Pharmaceutical topical composition of mupirocin

Publications (2)

Publication Number Publication Date
KR20130124504A KR20130124504A (ko) 2013-11-14
KR101776362B1 true KR101776362B1 (ko) 2017-09-07

Family

ID=44050874

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137011960A Active KR101776362B1 (ko) 2010-10-20 2011-10-19 무피로신 또는 그것의 염의 약학적 또는 수의학적 무수 국소 겔 조성물

Country Status (16)

Country Link
US (1) US9205149B2 (enExample)
EP (2) EP2444067A1 (enExample)
JP (1) JP5954745B2 (enExample)
KR (1) KR101776362B1 (enExample)
CN (1) CN103189048B (enExample)
AU (1) AU2011317636B2 (enExample)
BR (1) BR112013009371B1 (enExample)
CA (1) CA2814103C (enExample)
ES (1) ES2531846T3 (enExample)
MX (1) MX2013004394A (enExample)
NZ (1) NZ609655A (enExample)
PL (1) PL2629756T3 (enExample)
PT (1) PT2629756E (enExample)
RU (1) RU2563840C2 (enExample)
WO (1) WO2012052472A1 (enExample)
ZA (1) ZA201302560B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150095898A (ko) 2012-12-17 2015-08-21 라보라토리오스 오제르 파르마, 에스.엘. 겔 조성물

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150027831A (ko) * 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
EP3346998B1 (en) 2015-08-17 2025-04-16 Sidmak Laboratories (India) PVT. Ltd. Topical film delivery system
KR101717699B1 (ko) 2016-02-11 2017-03-17 아이큐어 주식회사 카타플라스마제용 자외선 경화형 하이드로젤 수지, 하이드로젤 및 이를 포함하는 카타플라스마제
WO2020141482A1 (en) * 2019-01-04 2020-07-09 Glenmark Specialty S.A. Pharmaceutical compositions comprising mupirocin
CN110090198B (zh) * 2019-05-09 2020-02-21 哈尔滨乾佰纳生物药业有限公司 一种具有生物粘附性的缓释型口腔溃疡凝胶及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1537857A1 (en) 2003-12-03 2005-06-08 Agis Industries (1983) Ltd Mupirocin compositions for topical use, a process of making same and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
GB8615669D0 (en) * 1986-06-26 1986-07-30 Beecham Group Plc Treatment
GB9321876D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Corp Novel composition
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
WO1999012520A1 (en) * 1997-09-11 1999-03-18 Smithkline Beecham Plc Compositions adapted for prolonged residence in the nasal pharynx
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
KR20070080823A (ko) * 2007-01-31 2007-08-13 주식회사 티디에스팜 활성약물 함유 상처 치료용 하이드로겔 제제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1537857A1 (en) 2003-12-03 2005-06-08 Agis Industries (1983) Ltd Mupirocin compositions for topical use, a process of making same and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150095898A (ko) 2012-12-17 2015-08-21 라보라토리오스 오제르 파르마, 에스.엘. 겔 조성물

Also Published As

Publication number Publication date
AU2011317636A1 (en) 2013-05-23
AU2011317636B2 (en) 2016-05-12
NZ609655A (en) 2014-08-29
KR20130124504A (ko) 2013-11-14
RU2013122845A (ru) 2014-11-27
PL2629756T3 (pl) 2015-06-30
RU2563840C2 (ru) 2015-09-20
ZA201302560B (en) 2014-06-25
CN103189048B (zh) 2014-11-26
CA2814103A1 (en) 2012-04-26
JP2013543518A (ja) 2013-12-05
EP2629756A1 (en) 2013-08-28
ES2531846T3 (es) 2015-03-20
CA2814103C (en) 2018-06-12
CN103189048A (zh) 2013-07-03
BR112013009371A2 (pt) 2016-07-26
US9205149B2 (en) 2015-12-08
JP5954745B2 (ja) 2016-07-20
PT2629756E (pt) 2015-05-21
US20130267587A1 (en) 2013-10-10
EP2629756B1 (en) 2014-12-24
BR112013009371B1 (pt) 2019-08-27
EP2444067A1 (en) 2012-04-25
MX2013004394A (es) 2013-08-21
WO2012052472A1 (en) 2012-04-26

Similar Documents

Publication Publication Date Title
KR101776362B1 (ko) 무피로신 또는 그것의 염의 약학적 또는 수의학적 무수 국소 겔 조성물
US20160090600A1 (en) Composition for external application comprising transcription factor decoy as active ingredient
Razdan et al. Levofloxacin loaded clove essential oil nanoscale emulsion as an efficient system against Pseudomonas aeruginosa biofilm
Rajpoot et al. Meropenem-loaded nanostructured lipid carriers for skin and soft tissue infection caused by Staphylococcus aureus: formulation, design, and evaluation
Dhamak et al. Enhanced therapeutic approach for diabetic foot ulcers: comparative study and characterisation of mupirocin-loaded nanosponge gel with marketed formulation for accelerating wound healing and in vivo evaluation
Ahmed et al. From bench to biology: Unraveling the efficiency of novel brijosomes for trans-tympanic drug delivery
Wahyuningsih et al. Combination Gel Formulation Extracts of Moringa Leaf and Red Betel Leaf as an Inhibitor of Acne-Causing Bacteria (Propionibacterium acne and Staphylococcus aureus)
Anwer et al. Punica granatum Loaded Glycerosomes for Antibacterial Effect in Skin Infections: Preparation, Optimization, In Vitro and In Vivo Characterization
CN103108624B (zh) 显示防腐效力的非水油性可注射制剂
CN112236163B (zh) 使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用
US20240299378A1 (en) Emulsion for use in the treatment of rosacea
EP4076412B1 (en) Gold- and graphene-based mixture and compositions and use thereof
Osborne et al. Alpha-linolenic acid-modified liposomes associate with and modulate antibiotic activity against Helicobacter pylori
US20230056335A1 (en) Topical formulation containing rapamycin
UA142740U (uk) Лікарський засіб у формі крему комплексної антимікробної, протизапальної та анестезуючої дії
UA126157C2 (uk) Лікарський засіб у формі крему комплексної антимікробної, протизапальної та анестезуючої дії
Patel Preparation and Evaluation of Topical Preparation of Norfloxacin
BR102018073592B1 (pt) Processo de obtenção de nanocarreadores lipídicos à base de manteiga de karité e óleo de argan modificados com polímeros bioadesivos, nanocarreadores lipídicos à base de manteiga de karité e óleo de argan modificados com polímeros bioadesivos e uso dos nanocarreadores lipídicos
WO2020116570A1 (ja) 皮膚外用剤
Mandimika Evaluation of the Pharmaceutical Availability of Erythromycin from Topical Formulations

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 9